Oncothermia Journal
Volume 5



Download the full journal


Cassutti V, Ballerini M, Baronzio GH, Szasz O (2012) Androtherm application for Peyronie disease (Phase I/II study). Oncothermia Journal 5:11-22

„Abstract
A pilot study is performed for Peyronie’s disease by oncothermia principle with a specially developed so called androthermia device. The case-studies and the preliminary efficacy results are promising, and show the feasibility of the new method to treat Peyronie’s disease in various stages.

Keywords: Peyronie’s disease, electric field, plaque, heat, androthermia“


Pang LKC (2012) Clinical Research on Integrative Treatment of Colon Carcinoma with Oncothermia and Clifford TCM Immune Booster. Oncothermia Journal 5:24-41

“Abstract
Nowadays oncology faces the challenge of non-toxic integrative therapies for cancer treatment. Clifford Hospital is devoted to this research and offers a full range of therapies, representing a synergy between the Traditional Chinese Medicine (TCM) and the state-of-art facilities of the Modern Western Medicine (MWM). Our present article reports research of the therapeutic efficacy and adverse reactions of integrative treatment of colon carcinoma with Oncothermia (OT) and Clifford TCM Immune Booster (CIB). The clinical study involved 157 patients in three-arms of treatments: CIB alone, OT alone and OT+ CIB combined. Results definitely prefer the combination therapy, which shows synergy of OT with CIB. Keywords: Clifford TCM Immune Booster, Oncothermia, Traditional Chinese Medicine, randomized controlled clinical trial, colon carcinoma….”


Lee DY (2012) Complete Remission of SCLC with Chemotherapy and Oncothermia (Case report). Oncothermia Journal 5:43-51

“Abstract Nowadays, most oncologists have treated their patients with solid tumors by using hyperthermia with good results even though they have a large amount of different thoughts on the mechanism of oncological hyperthermia. We have treated our patients with solid tumor confirmed lung carcinoma with chemotherapy or radiotherapy with oncothermia [1] at the Department of Thoracic and Cardio-vascular Surgery at Gangnam Severance hospital since Jan, 2008. Our objective in this paper showing a case of a patient with Small Cell Lung Cancer (SCLC). The patient was and treated by chemotherapy andand oncothermia in 2008, at the Thoracic and Cardio-vascular Surgery Department, Gangnam Severance Hospital, Seoul, Korea. We report a complete remission of this patient after chemotherapy with oncothermia (2 cycles) in follow-up for 3 years….”


Seong MY, Jung SL (2012) Case of Abscopal effect with Metastatic Non-Small-Cell Lung Cancer. Oncothermia Journal 5:53-57

“Abstract
The abscopal effect is originally defined as the observational effect of radiation therapy at site distant to the treated field. Recently systemic effects of local radiotherapy including hyperthermia and immunotherapy have received attention as a new therapeutic modality. We report a case of abscopal effect observed in a patient with multiple metastatic non-small-cell lung cancer. Patient was treated with fractional radiotherapy, modulated electro-hyperthermia (oncothermia) and granulocyte-colony stimulating factor (GM-CSF). Key words: Abscopal effect, Radiotherapy, Hyperthermia, GM-CSF, Non-small-cell lung cancer…”


Hofmann H (2012) Bluttests für onkologische und immunologische Fragestellungen. Oncothermia Journal 5:59-60

„Der Erfolg einer Krebstherapie hängt ganz entscheidend vom Zeitpunkt der Diagnose und der Charakterisierung des Tumors z.B. hinsichtlich der Invasivität und Therapieresistenz ab, denn je früher die Erkrankung entdeckt und je genauer die Tumoren beurteilt werden können, desto höher sind die Heilungschancen. Aufgrund dessen ist es von großer Wichtigkeit, dass diagnostische Verfahren etabliert werden, die dies ermöglichen.“


Jückstock JK, Eberhadt B, Sommer HL (2012) Locoregional hyperthermia in combination with chemotherapy for metastatic breast cancer patients: The Mammatherm – trial. Oncothermia Journal 5:62-65

„Abstract Treatment options for patients with metastatic breast cancer should be both as effective and preferably as little toxic as possible. However to date there is no standard therapy available but treatment regimens for metastatic breast cancer vary much. Locoregional hyperthermia might show additive effects to chemotherapy due to an increased perfusion and a simultaneous occurring of interstitial acidosis in tumor tissue….“


Krautkramer S (2012) Neue Herausforderungen im Praxis- und Klinikmanagement: Prozessoptimierung durch echtes Factoring. Oncothermia Journal 5:67-71

„1.) Ausgangslage Moderne Behandlungsmethoden, zunehmende Bürokratie im Berufsalltag sowie ein Wandel von Zahlungsmoral und Wertvorstellungen in weiten Teilen der Bevölkerung stellen das Praxis- und Klinikmanagement immer wieder vor neue Herausforderungen. Für die Privatabrechnung – eine entscheidende Erlösquelle sowohl im ambulanten als auch im stationären Bereich – sind aufgrund dieser Veränderungen insbesondere zwei Konsequenzen auszumachen.“


Lüdecke G (2012) Hyperthermie Chemotherapie beim Harnblasenkarzinom. Oncothermia Journal 5:73-75

„Abstract Das Harnblasenkarzinom ist ein relativ häufiger maligner Tumor, der sich grundsätzlich in zwei Risikogruppen aufteilen lässt. Einerseits gibt es das so genannte oberflächliche oder nicht muskelinvasive Harnblasenkarzinom und andererseits gibt es das muskelinvasive Harnblasenkarzinom. Das Erstere wird endoskopisch operativ diagnostiziert und therapiert, während das zweite durch radikale chirurgische Maßnahmen mittels der Zystektomie oder einer systemischen Radiochemotherapie behandelt wird….“


Hegyi G, Bingsheng H, Ji’an L, Szasz O, Szasz A (2012) Oncothermia Journal 5:77-93

“Abstract
Aim of this article to show the possibility and great advantage of the synergy of oncothermia with traditional Chinese medicine, on the common basis of equilibrium demand. We use the recognition of the deviations from the complex harmony of the organism or its part for selection to act properly.
Introduction Hyperthermia is an ancient oncology method. It is the very first treatment modality for this type of disease, having 5000 year history [1], based on the Sun as the overall curative force in ancient Egypt….”


 

Oncotherm